Pharmaceuticals
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Research at Biogen Source: Biogen Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. The Japanese drugmaker and its partner Biogen last week released an additional analysis of clinical trials of the monoclonal antibody drug, which is also known as lecanemab. Alzheimer’s disease continued to progress at a slower rate […]
Read More
Carl Icahn says Illumina’s appeal of FTC order to divest Grail is ‘an almost impossible battle’
Carl Icahn, chairman of Icahn Enterprises Holdings Scott Eelis | Bloomberg | Getty Images Carl Icahn on Wednesday said Illumina‘s efforts to appeal a Federal Trade Commission order to divest the highly contested Grail acquisition “is an almost impossible battle.” Illumina on Monday told CNBC it intends to appeal the FTC’s order in federal court, […]
Read More
Johnson & Johnson shares rise after company proposes baby powder cancer settlement
In this photo illustration a bottle of Johnson & Johnson baby powder is displayed on a table on November 12, 2021 in San Anselmo, California. Justin Sullivan | Getty Images Johnson & Johnson shares on Wednesday climbed after the company proposed paying $8.9 billion to settle thousands of claims that its baby powder and other […]
Read More
Eli Lilly says experimental Alzheimer’s drug reduces brain plaque in early study
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli Lilly‘s experimental Alzheimer’s drug lowered levels of brain plaque in patients who are in the earliest […]
Read More
Frank founder criminally charged with fraud over $175 million JPMorgan deal
Charlie Javice, Founder/CEO of Frank, which is a college financial aid start-up. Source: JP Morgan The Justice Department on Tuesday charged Charlie Javice, founder of college financial planning platform Frank, with defrauding JPMorgan Chase of $175 million. Javice, 31, is charged with “falsely and dramatically” inflating the number of customers Frank actually had in a […]
Read More
Check out stay: Biden speaks in Minnesota as Cummins announces $1 billion electrical power investment decision
(The stream is slated to begin at 3:25 p.m. ET. Make sure you refresh the web site if you do not see a movie over at that time.) President Joe Biden is in Fridley, Minn. on Monday touring a Cummins facility as the company announced it will devote $1 billion in building cleaner engines. Cummins […]
Read More
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
Francis deSouza, chief executive officer of Illumina Inc., during a panel session on day three of the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 19, 2023. Stefan Wermuth | Bloomberg | Getty Images The Federal Trade Commission on Monday ordered Illumina to divest its controversial acquisition of cancer test developer Grail, saying […]
Read More
Carl Icahn blasts Illumina for nearly doubling CEO’s pay despite steep drop in market value
Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn blasted Illumina for nearly doubling its CEO’s pay last year despite a dramatic drop in the biotech company’s market value since closing a controversial deal. “I’d find it comical, if it wasn’t so reprehensible that […]
Read More
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Rafael Henrique | Lightrocket | Getty Images Illumina on Thursday urged shareholders to reject Carl Icahn’s three board nominees at this year’s annual meeting, saying they would “threaten the progress” of the biotech company’s core business. “Carl Icahn’s involvement with Illumina risks the long-term success of the Company, and his director nominees bring no relevant […]
Read More
People taking obesity drugs Ozempic and Wegovy gain weight once they stop medication
This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication “Ozempic” (semaglutide) made by Danish pharmaceutical company “Novo Nordisk”. Joel Saget | AFP | Getty Images Patients taking blockbuster obesity drugs Ozempic or Wegovy will pack the pounds back on after they stop taking the medications. “I think this is what we […]
Read More